Zoetis

YTD

ALL

Trade Zoetis 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About ZTS

Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health technology. It operates through the United States and International geographical segments.

CEO

Kristin C. Peck

CEOKristin C. Peck

Employees

14,500

Employees14,500

Headquarters

Parsippany, New Jersey

HeadquartersParsippany, New Jersey

Founded

1952

Founded1952

Employees

14,500

Employees14,500

ZTS Key Statistics

Market cap

31.06B

Market cap31.06B

Price-Earnings ratio

12.49

Price-Earnings ratio12.49

Dividend yield

2.73%

Dividend yield2.73%

Average volume

5.78M

Average volume5.78M

High today

$75.92

High today$75.92

Low today

$73.38

Low today$73.38

Open price

$74.67

Open price$74.67

Volume

5.32M

Volume5.32M

52 Week high

$160.48

52 Week high$160.48

52 Week low

$71.47

52 Week low$71.47

Stock Snapshot

As of today, Zoetis(ZTS) shares are valued at $74.99. The company's market cap stands at 31.06B, with a P/E ratio of 12.49 and a dividend yield of 2.73%.

On 2026-07-15, Zoetis(ZTS) stock moved within a range of $73.38 to $75.92. With shares now at $74.99, the stock is trading +2.2% above its intraday low and -1.2% below the session's peak.

Trading volume for Zoetis(ZTS) stock has reached 5.32M, versus its average volume of 5.78M.

The stock's 52-week range extends from a low of $71.47 to a high of $160.48.

ZTS News

Investing.com 20h

Zoetis to acquire veterinary teleradiology platform VitalRADS - Investing.com

...

TipRanks 21h

Zoetis enters agreement to acquire VitalRADS, terms not disclosed

Zoetis (ZTS) announced its agreement to acquire VitalRADS, a veterinary teleradiology services platform. Building on the partnership with VitalRADS that Zoetis...

Simply Wall St 4d

New EU Poultry Vaccine Approval Might Change The Case For Investing In Zoetis

Zoetis recently received European Commission marketing authorization for Poulvac Procerta HVT-ND, a recombinant vector vaccine that protects chickens against Ne...

Analyst ratings

52%

of 21 ratings

Buy

52.4%

Hold

47.6%

Sell

More ZTS News

Simply Wall St 6d

Zoetis Wins EU Vaccine Approval With Undervalued View Still In Focus

Zoetis (ZTS) stock is in focus after the European Commission granted marketing authorization for Poulvac Procerta HVT-ND, a single-dose poultry vaccine that pro...

People also own

Based on the portfolios of people who own ZTS. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.